Cellectis announced the appointment of Dr. Loan Hoang-Sayag to the role of Chief Medical Officer. Dr. Hoang-Sayag's responsibilities will include bringing the company's product candidates into clinical stage development, as well as strategic and operational management of all therapeutic activities for Cellectis. Dr. Hoang-Sayag joins Cellectis from Quintiles Transnational, where she was most recently Senior Director of Medical Science.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 EUR | 0.00% | -9.74% | -36.32% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.32% | 189M | |
+35.14% | 51.51B | |
-7.43% | 39.03B | |
+35.06% | 38.91B | |
-10.62% | 26.68B | |
+11.63% | 26.13B | |
-17.77% | 19.91B | |
+40.52% | 13.71B | |
+30.70% | 12.38B | |
-3.41% | 11.74B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis Appoints Dr. Loan Hoang-Sayag to the Role of Chief Medical Officer